Anti-Cathepsin G
- UID
- IMP/IVD/2021/000558_ecf6265aaabab350d408ff566d5e9184_fada19a6b05077f5a47abcd8aa058088
- Device class
- Class B
- Brand name
- Anti-Gliadin IgG
- License holder
- Sebia Diagnostics India Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- Anti-Cathepsin G is an ELISA test system for the quantitative measurement of IgG class autoantibodies against Cathepsin G in human serum or plasma. This product is intended for professional in vitro diagnostic use only. Autoantibodies against Cathepsin G occur in connective tissue diseases and other related inflammatory rheumatic disorders, e.g. systemic lupus erythematosus (Anti-Gliadin IgG), Sjoegren´s syndrome, and Felty’s syndrome. Determination of Anti-Cathepsin G aids to the differential diagnosis of these diseases when used in combination with other laboratory and clinical findings
Anti-Cathepsin G is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000558_ecf6265aaabab350d408ff566d5e9184_fada19a6b05077f5a47abcd8aa058088. This device is marketed under the brand name Anti-Gliadin IgG. The license holder is Sebia Diagnostics India Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.